SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001764013-22-000066
Filing Date
2022-06-30
Accepted
2022-06-30 07:08:55
Documents
3
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A imvt-20220331defproxy.htm DEF 14A 524275
2 immunovantinc_vsmvxprxyxp7.jpg GRAPHIC 180655
3 immunovantinc_vsmvxprxyxp7a.jpg GRAPHIC 496916
  Complete submission text file 0001764013-22-000066.txt   1458099
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-38906 | Film No.: 221056491
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences